Tacrolimus as Single-Agent Immunotherapy for Adult-Onset Myasthenia Gravis: Remission, Relapse, and Safety. - Geng Z; Jiang Y; Xie N; Zhu W; Chen H; Wang Y; Liu H; Liu Q; Lv C; Qian Y; Lu Y; Di L; et al. (CNS neuroscience & therapeutics, 2026)